Cargando…

Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients

In the last two decades Nd: YAG laser has become a standard of treatment of telangiectasias of the lower limbs in C(1)EAP stage of chronic venous insufficiency. This paper shows the results of a two years study period of telangiectasias of lower limbs with Nd: YAG laser conducted in a specialised ce...

Descripción completa

Detalles Bibliográficos
Autores principales: IANOSI, N.G., CALBUREANU-POPESCU, M.X., DRAGUSIN, L., IANOSI, S.L., TUTUNARU, C.V., NEAGOE, C.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311228/
https://www.ncbi.nlm.nih.gov/pubmed/30647943
http://dx.doi.org/10.12865/CHSJ.44.03.06
_version_ 1783383573288452096
author IANOSI, N.G.
CALBUREANU-POPESCU, M.X.
DRAGUSIN, L.
IANOSI, S.L.
TUTUNARU, C.V.
NEAGOE, C.D.
author_facet IANOSI, N.G.
CALBUREANU-POPESCU, M.X.
DRAGUSIN, L.
IANOSI, S.L.
TUTUNARU, C.V.
NEAGOE, C.D.
author_sort IANOSI, N.G.
collection PubMed
description In the last two decades Nd: YAG laser has become a standard of treatment of telangiectasias of the lower limbs in C(1)EAP stage of chronic venous insufficiency. This paper shows the results of a two years study period of telangiectasias of lower limbs with Nd: YAG laser conducted in a specialised centre in this type of procedures. The study group consisted of 446 patients (21 males and 425 females) with telangiectasias (C(1)EAP) on the lower limbs between January 2016-December 2017. The patients had to complete a form in which they noted the initial state on a scale from 1 to 10 but also the result of the treatment and the intensity of the pain during the laser treatment. Moreover, the doctor also evaluated the results of the treatment for each and every patient taking also into account the initial phase of the disease. We observed a significant improvement of the clinical appearance (the reduction of telangiectasias) almost in the entire study group, regardless of the gender and the age, but the intensity of the pain was higher in men and in persons under the age of 30. Based on these data we can conclude that Nd: YAG laser represents a minimally invasive therapeutic option with minor side effects and major aesthetic results and furthermore it can be combined with several other methods (microsclerotherapy, radiofrequency, complex surgery) in order to improve peripheral chronic venous insufficiency.
format Online
Article
Text
id pubmed-6311228
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medical University Publishing House Craiova
record_format MEDLINE/PubMed
spelling pubmed-63112282019-01-15 Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients IANOSI, N.G. CALBUREANU-POPESCU, M.X. DRAGUSIN, L. IANOSI, S.L. TUTUNARU, C.V. NEAGOE, C.D. Curr Health Sci J Original Paper In the last two decades Nd: YAG laser has become a standard of treatment of telangiectasias of the lower limbs in C(1)EAP stage of chronic venous insufficiency. This paper shows the results of a two years study period of telangiectasias of lower limbs with Nd: YAG laser conducted in a specialised centre in this type of procedures. The study group consisted of 446 patients (21 males and 425 females) with telangiectasias (C(1)EAP) on the lower limbs between January 2016-December 2017. The patients had to complete a form in which they noted the initial state on a scale from 1 to 10 but also the result of the treatment and the intensity of the pain during the laser treatment. Moreover, the doctor also evaluated the results of the treatment for each and every patient taking also into account the initial phase of the disease. We observed a significant improvement of the clinical appearance (the reduction of telangiectasias) almost in the entire study group, regardless of the gender and the age, but the intensity of the pain was higher in men and in persons under the age of 30. Based on these data we can conclude that Nd: YAG laser represents a minimally invasive therapeutic option with minor side effects and major aesthetic results and furthermore it can be combined with several other methods (microsclerotherapy, radiofrequency, complex surgery) in order to improve peripheral chronic venous insufficiency. Medical University Publishing House Craiova 2018 2018-07-15 /pmc/articles/PMC6311228/ /pubmed/30647943 http://dx.doi.org/10.12865/CHSJ.44.03.06 Text en Copyright © 2018, Medical University Publishing House Craiova http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
IANOSI, N.G.
CALBUREANU-POPESCU, M.X.
DRAGUSIN, L.
IANOSI, S.L.
TUTUNARU, C.V.
NEAGOE, C.D.
Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title_full Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title_fullStr Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title_full_unstemmed Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title_short Treatment of Lower Limbs Telangiectasias with Nd: Yag Laser-Prospective Study on 446 Patients
title_sort treatment of lower limbs telangiectasias with nd: yag laser-prospective study on 446 patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311228/
https://www.ncbi.nlm.nih.gov/pubmed/30647943
http://dx.doi.org/10.12865/CHSJ.44.03.06
work_keys_str_mv AT ianosing treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients
AT calbureanupopescumx treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients
AT dragusinl treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients
AT ianosisl treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients
AT tutunarucv treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients
AT neagoecd treatmentoflowerlimbstelangiectasiaswithndyaglaserprospectivestudyon446patients